Baolingbao Biology Co.,Ltd. (SHE:002286)

China flag China · Delayed Price · Currency is CNY
9.23
+0.03 (0.33%)
Jun 2, 2026, 3:04 PM CST
Market Cap3.51B +1.7%
Revenue (ttm)2.81B +11.0%
Net Income154.40M +11.6%
EPS0.41 +8.6%
Shares Out 380.57M
PE Ratio22.36
Forward PE17.42
Dividend0.12 (1.30%)
Ex-Dividend DateJul 3, 2025
Volume7,983,000
Open9.25
Previous Close9.20
Day's Range9.12 - 9.30
52-Week Range8.62 - 13.40
Beta0.57
Analystsn/a
Price Targetn/a
Earnings DateAug 27, 2026

About Baolingbao Biology

Baolingbao Biology Co.,Ltd. researches and develops, manufactures, and sells a range of functional sugars in China. The company offers prebiotics, such as isomaltooligosaccharides, galactooligosaccharides, fructooligosaccharides, bagasse trisaccharides, and xylooligosaccharides; sugar alcohols and new sugar source products, including erythritol, trehalose, crystalline fructose, alodonose, and maltose; dietary fiber products comprising polydextrose and resistant dextrin; modified, waxy maize, and corn starch products; starch sugar products, incl... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1997
Employees 1,505
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002286
Full Company Profile

Financial Performance

In 2025, Baolingbao Biology's revenue was 2.75 billion, an increase of 14.54% compared to the previous year's 2.40 billion. Earnings were 150.63 million, an increase of 35.50%.

Financial Statements